Investigation of the Genetics of Hematologic Diseases

Plain-language summary

This study explores the genetic basis of hematologic (blood) diseases. Individuals receiving therapy or expert consultation for a non-malignant blood disorder, myelodysplastic syndrome (MDS) or myeloproliferative neoplasm (MPN), along with their first-, second- or third-degree relatives, can take part. It is a non-phase study and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

St. Jude Children's Research Hospital

Start date

6/17/2016

Estimated completion

7/1/2050

Countries

United States

Related genes

Locations

• Memphis, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* An individual (proband) receiving therapy or expert consultation regarding a non-malignant hematologic disorder, MDS or MPN.
* A biologically-related individual to the identified proband to include: first, second or third degree relatives.

Exclusion Criteria:

* None